RECURRENT TUMOR
Clinical trials for RECURRENT TUMOR explained in plain language.
Never miss a new study
Get alerted when new RECURRENT TUMOR trials appear
Sign up with your email to follow new studies for RECURRENT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for recurrent glioblastoma: experimental drug LMP744 enters human trials
Disease control Recruiting nowThis study tests a new drug called LMP744 in people whose glioblastoma has come back after standard treatment. The drug is designed to kill cancer cells by blocking a key growth signal and interfering with DNA repair. Participants will receive the drug through a vein for 5 days e…
Matched conditions: RECURRENT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Laser zaps recurrent brain tumors: new trial tests minimally invasive option
Disease control Recruiting nowThis study is for people whose brain metastases have come back or caused radiation damage after initial treatment. It compares a laser-based procedure (LITT) plus standard care against standard care alone (steroids or repeat radiation). The goal is to see if LITT can better contr…
Matched conditions: RECURRENT TUMOR
Phase: NA • Sponsor: Monteris Medical • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC